Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 5 (TLR5) is a pattern recognition receptor that detects bacterial flagellin, activating innate immune responses. Upon binding flagellin, TLR5 initiates intracellular signaling via the adaptor protein MyD88, leading to activation of NF-κB and production of pro-inflammatory cytokines. Dysregulation of TLR5 is implicated in inflammatory bowel disease, rheumatoid arthritis, bone loss, and various cancers. TLR5 is a therapeutic target for cancer immunotherapy.
Modulation of TLR5 activity to enhance anti-tumor immunity or reduce pathological inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 5 (TLR5).